01 10Lamictal
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 744
2019 Revenue in Millions : 785
Growth (%) : -5
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 647
2020 Revenue in Millions : 736
Growth (%) : -11
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 630
2021 Revenue in Millions : 647
Growth (%) : -3
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 470
2022 Revenue in Millions : 630
Growth (%) : -15
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 754
2014 Revenue in Millions : 754
Growth (%) : 0%
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -4.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 761
2015 Revenue in Millions : 658
Growth (%) : 16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 917
2016 Revenue in Millions : 866
Growth (%) : 6
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 865
2017 Revenue in Millions : 865
Growth (%) : 0%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 702
2018 Revenue in Millions : 806
Growth (%) : -13
LOOKING FOR A SUPPLIER?